Clinics in Dermatology
Volume 26, Issue 4 , Pages 367-374 , July 2008

Efficacy and safety of innovative cosmeceuticals

  • Xing-Hua Gao, MD

      Affiliations

    • Department of Dermatology, No. 1 Hospital of China Medical University, Shenyang, China
    • ,
  • Li Zhang, MD

      Affiliations

    • Department of Dermatology, No. 1 Hospital of China Medical University, Shenyang, China
    • ,
  • Huachen Wei, MD

      Affiliations

    • Department of Dermatology, The Mount Sinai Medical Center, New York, USA
    • ,
  • Hong-Duo Chen, MD

      Affiliations

    • Department of Dermatology, No. 1 Hospital of China Medical University, Shenyang, China
    • Corresponding Author InformationCorresponding author. Tel.: +86 24 83282642; fax: +86 24 83282633.

References 

  1. Kligman A. Cosmeceuticals: do we need a new category?. In:  Elsner P,  Maiback H editor. Cosmeceuticals. New York: Marcel Dekker; 2000;p. 1
  2. Dureja H, Kaushik D, Gupta M, et al. Cosmeceutical: an emerging concept. Indian J Pharmacol. 2005;37:155–159
  3. Lee ES, Kim JH, Sungbin IM, et al. Application of computerized image analysis in pigmentary skin diseases. Int J Dermatol. 2001;40:45–49
  4. Yoshimura K, Sato K, Aiba-Kojima E, et al. Repeated treatment protocols for melasma and acquired dermal melanocytosis. Dermatol Surg. 2006;32:365–371
  5. Boissy RE, Visscher M, DeLong MA. DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency. Exp Dermatol. 2005;14:601–608
  6. Chakraborty AK, Funasaka Y, Komoto M, et al. Effect of arbutin on melanogenic proteins in human melanocytes. Pigment Cell Res. 1998;11:206–212
  7. Maeda K, Fukuda M. Arbutin: mechanism of its depigmenting action in human melanocyte culture. J Pharmacol Exp Ther. 1996;276:765–769
  8. Nakamura K, Yoshida M, Uchiwa H. Down-regulation of melanin synthesis by a biphenyl derivative and its mechanism. Pigment Cell Res. 2003;16:494–500
  9. Usuki A, Ohashi A, Sato H, et al. The inhibitory effect of glycolic acid and lactic acid on melanin synthesis in melanoma cells. Exp Dermatol. 2003;12(Suppl 2):43–50
  10. Galcia A, Fulton JE. The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions. Dermatol Surg. 1996;22:443–447
  11. Moon KY, Ahn KS, Lee J, et al. Kojic acid, a potential inhibitor of NF-kappaB activation in transfectant human HaCaT and SCC-13 cells. Arch Pharm Res. 2001;24:307–311
  12. Nohynek GJ, Kirkland D, Marzin D, et al. An assessment of the genotoxicity and human health risk of topical use of kojic acid [5-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one]. Food Chem Toxicol. 2004;42:93–105
  13. Wan HM, Chen CC, Chang TS, et al. Combining induced mutation and protoplasting for strain improvement of Aspergillus oryzae for kojic acid production. Biotechnol Lett. 2004;26:1163–1166
  14. Kim DH, Hwang JS, Baek HS, et al. Development of 5-[(3-aminopropyl)phosphinooxy]-2-(hydroxymethyl)-4H-pyran-4-one as a novel whitening agent. Chem Pharm Bull (Tokyo). 2003;51:113–116
  15. Balina LM, Graupe K. The treatment of melasma. 20% azelaic acid versus 4% hydroquinone cream. Int J Dermatol. 1991;30:893–895
  16. Draelos ZD. In: Cosmeceuticals: procedures in cosmetic dermatology. Philadelphia: Elsevier Saunders; 2005;p. 71–79
  17. Ortonne JP. Retinoid therapy of pigmentary disorders. Dermatol Ther. 2006;19:280–288
  18. Gao XH, Chen HD, Kligman AM. Topical tretinoin for photoaging: the China experience. J Appl Cosmetol. 1997;15:77–82
  19. Yoshimura M, Watanabe Y, Kasai K, et al. Inhibitory effect of an ellagic acid–rich pomegranate extract on tyrosinase activity and ultraviolet-induced pigmentation. Biosci Biotechnol Biochem. 2005;69:2368–2373
  20. Yokota T, Nishio H, Kubota Y. The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. Pigment Cell Res. 1998;11:355–361
  21. Nerya O, Vaya J, Musa R, et al. Glabrene and isoliquiritigenin as tyrosinase inhibitors from licorice roots. J Agric Food Chem. 2003;51:1201–1207
  22. Kim HJ, Seo SH, Lee BG, et al. Identification of tyrosinase inhibitors from Glycyrrhiza uralensis. Planta Med. 2005;71:785–787
  23. Kameyama K, Sakai C, Kondoh S, et al. Inhibitory effect of magnesium l-ascorbyl-2-phosphate (VC-PMG) on melanogenesis in vitro and in vivo. J Am Acad Dermatol. 1996;34:29–33
  24. Curto EV, Kwong C, Hermersdorfer H, et al. Inhibitors of mammalian melanocyte tyrosinase: in vitro comparisons of alkyl esters of gentisic acid with other putative inhibitors. Biochem Pharmacol. 1999;57:663–672
  25. Kim DS, Park SH, Kwon SB, et al. Sphingosylphosphorylcholine-induced ERK activation inhibits melanin synthesis in human melanocytes. Pigment Cell Res. 2006;19:146–153
  26. Okombi S, Rival D, Bonnet S, et al. Analogues of N-hydroxycinnamoylphenalkylamides as inhibitors of human melanocyte-tyrosinase. Bioorg Med Chem Lett. 2006;16:2252–2255
  27. Kim DS, Kim SY, Chung JH, et al. Delayed ERK activation by ceramide reduces melanin synthesis in human melanocytes. Cell Signal. 2002;14:779–785
  28. Hale LP. Zinc alpha-2-glycoprotein regulates melanin production by normal and malignant melanocytes. J Invest Dermatol. 2002;119:464–470
  29. Rawlings AV, Harding CR. Moisturization and skin barrier function. Dermatol Ther. 2004;175(Suppl 1):43–48
  30. Baumann L. In: Cosmetic dermatology: principles and practice. Boston: The McGraw-Hill Companies Medical Publishing Division; 2002;p. 29
  31. Schzwarts R, Centurion SA. Moisturizers. eMedicine. 2006;2
  32. Grove G, Zerweck C. An evaluation of the moisturizing and anti-itch effects of a lactic acid and pramoxine hydrochloride cream. Cutis. 2004;73:135–139
  33. Ebner F, Heller A, Rippke F, et al. Topical use of dexpanthenol in skin disorders. Am J Clin Dermatol. 2002;3:427–433
  34. Chamlin SL, Kao J, Frieden IJ, et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol. 2002;47:198–208
  35. Soma Y, Kashima M, Imaizumi A, et al. Moisturizing effects of topical nicotinamide on atopic dry skin. Int J Dermatol. 2005;44:197–202
  36. Draelos ZD, Ertel K, Berge C. Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea. Cutis. 2005;76:135–141
  37. El-Kadi KN, Rawlings AV, Feinberg C, et al. Broad specificity alkaline proteases efficiently reduce the visual scaling associated with soap-induced xerosis. Arch Dermatol Res. 2001;293:500–507
  38. Glogau RG. Chemical peeling and aging skin. J Geriatr Dermatol. 1994;12:31
  39. Lee S, Lim JM, Jin MH, et al. Partially purified paeoniflorin exerts protective effects on UV-induced DNA damage and reduces facial wrinkles in human skin. J Cosmet Sci. 2006;57:57–64
  40. Kim SW, Jo BK, Jeong JH, et al. Induction of extracellular matrix synthesis in normal human fibroblasts by anthraquinone isolated from Morinda citrifolia (Noni) fruit. J Med Food. 2005;8:552–555
  41. Chi YS, Heo MY, Chung JH, et al. Effects of the chestnut inner shell extract on the expression of adhesion molecules, fibronectin and vitronectin, of skin fibroblasts in culture. Arch Pharm Res. 2002;25:469–474
  42. Grossman R. The role of dimethylaminoethanol in cosmetic dermatology. Am J Clin Dermatol. 2005;6:39–47
  43. Hoppe U, Bergemann J, Diembeck W, et al. Coenzyme Q10, a cutaneous antioxidant and energizer. Biofactors. 1999;9:371–378
  44. Kullavanijaya P, Lim H. Photoprotection. J Am Acad Dermatol. 2005;52:937–958
  45. Wulf HC, Sandby-Moller J, Kobayasi T, et al. Skin aging and natural photoprotection. Micron. 2004;35:185–191
  46. Varani J, Schuger L, Dame MK, et al. Reduced fibroblast interaction with intact collagen as a mechanism for depressed collagen synthesis in photodamaged skin. J Invest Dermatol. 2004;122:1471–1479
  47. Naru E, Suzuki T, Moriyama M, et al. Functional changes induced by chronic UVA irradiation to cultured human dermal fibroblasts. Br J Dermatol. 2005;153(Suppl 2):6–12
  48. Sharma S, Kaur IP. Development and evaluation of sesamol as an antiaging agent. Int J Dermatol. 2006;45:200–208
  49. Stratigos AJ, Katsambas AD. The role of topical retinoids in the treatment of photoaging. Drugs. 2005;65:1061–1072
  50. Baumann L, Vujevich J, Halem M, et al. Open-label pilot study of alitretinoin gel 0.1% in the treatment of photoaging. Cutis. 2005;76:69–73
  51. Wei H, Saladi R, Lu Y, et al. Isoflavone genistein: photoprotection and clinical implications in dermatology. J Nutr. 2003;133(Suppl):3811S–3819S
  52. Fitzpatrick RE, Rostan EF. Double-blind, half-face study comparing topical vitamin C and vehicle for rejuvenation of photodamage. Dermatol Surg. 2002;28:231–236
  53. An BJ, Kwak JH, Son JH, et al. Physiological activity of irradiated green tea polyphenol on the human skin. Am J Chin Med. 2005;33:535–546
  54. Morlev N, Clifford T, Salter L, et al. The green tea polyphenol (−)-epigallocatechin gallate and green tea can protect human cellular DNA from ultraviolet and visible radiation-induced damage. Photodermatol Photoimmunol Photomed. 2005;21:15–22
  55. Tobi SE, Gilbert M, Paul N, et al. The green tea polyphenol, epigallocatechin-3-gallate, protects against the oxidative cellular and genotoxic damage of UVA radiation. Int J Cancer. 2002;102:439–444
  56. Chow HH, Cai Y, Hakim IA, et al. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res. 2003;15:3312–3319
  57. Wyszko E, Barciszewska MZ, Markiewicz M, et al. ‘Action-at-a distance’ of a new DNA oxidative damage product 6-furfuryl-adenine (kinetin) on template properties of modified DNA. Biochim Biophys Acta. 2003;1625:239–245
  58. Berge U, Kristensen P, Rattan SI. Kinetin-induced differentiation of normal human keratinocytes undergoing aging in vitro. Ann N Y Acad Sci. 2006;1067:332–336
  59. Verbeke P, Siboska GE, Clark BF, et al. Kinetin inhibits protein oxidation and glycoxidation in vitro. Biochem Biophys Res Commun. 2000;276:1265–1270
  60. Olsen A, Siboska GE, Clark BF, et al. N(6)-F-Furfuryladenine, kinetin, protects against Fenton reaction–mediated oxidative damage to DNA. Biochem Biophys Res Commun. 1999;265:499–502

☆ This article was supported by the Program for New Century Excellent Talents in University (NCEP-04-0287).

PII: S0738-081X(08)00014-X

doi: 10.1016/j.clindermatol.2008.01.013

Clinics in Dermatology
Volume 26, Issue 4 , Pages 367-374 , July 2008

Article Tools